Valued at RM3.9 billion, the acquisition marks a major milestone in IHH’s growth strategy, strengthening our leadership position and reinforcing our commitment to providing world-class healthcare in Malaysia.

 “Island Hospital presents a transformative opportunity for us in Malaysia. Its leading position in Penang, extensive specialist pool and clinical offerings, as well as its status as the hospital of choice for foreign patients, make it an asset that complements our growth plans in the country,” says Dr Prem Kumar Nair, Group CEO, IHH Healthcare.

Island Hospital is a 600-bed facility with 119 resident and visiting specialists across key disciplines, including orthopaedics, cardiology, oncology, gastroenterology, and general surgery. With 9 Centres of Excellence, it is renowned for its comprehensive medical services and high-quality patient care. Accredited by The Australian Council on Healthcare Standards (ACHS), it is one of the few hospitals in Southeast Asia to hold ACHS Centres of Excellence in cancer care and cardiology. Island Hospital is also the leading hospital for medical tourism, attracting approximately 1 in 3 inbound foreign patients to Malaysia.

 “With the acquisition of Island Hospital, we are strengthening IHH Healthcare Malaysia’s footprint in Penang and enhancing our position as the leading private healthcare provider in Malaysia. This strategic move affirms our commitment to excellence and dedication to providing world-class healthcare, both for our local and international patients who place their trust in us,” says Jean-François Naa, CEO of IHH Healthcare Malaysia.

Penang is IHH’s second largest cluster in Malaysia after the Klang Valley region. Post-acquisition, IHH will have over 1,000 operational beds in Penang, reinforcing our position as a premier healthcare provider both locally and internationally. The Group will also gain a larger share of medical travel into Malaysia, elevating our support for the country’s medical tourism aspirations.